← Back to patent-cliff list
CAS 1637784-91-8
1-allyl-7-chloro-1,2,3,4-tetrahydro-5H-benzo[b]azepin-5-one
Codes：TOLV-023
Application context (from source-drug indications)
常染色体显性多囊肾病托伐普坦纤维化托伐普坦低钠血症托伐普坦心脏衰竭托伐普坦抗利尿激素分泌失调综合征托伐普坦
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 托伐普坦Tolvaptan | Tier B — Position early | 2028 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
7-chloro-1,2,3,4-tetrahydro-5H-benzo[b]azepin-5-one→3-methyl-4-nitrobenzoyl chloride→7-chloro-1-(2-methyl-4-nitrobenzoyl)-1,2,3,4-tetrahydro-5H-benzo[b]azepin-5-one→1-(4-amino-2-methylbenzoyl)-7-chloro-1,2,3,4-tetrahydro-5H-benzo[b]azepin-5-one→2-methylbenzoyl chloride→N-(4-(7-chloro-5-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide→5-chloro-2-fluorobenzaldehyde→diallylamine→5-chloro-2-(diallylamino)benzaldehyde→1-allyl-7-chloro-2,3,4,5-tetrahydro-1H-2,5-epoxybenzo[b]azepine→1-allyl-7-chloro-1,2,3,4-tetrahydro-5H-benzo[b]azepin-5-one
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.